Canada markets closed

  • S&P/TSX
    18,060.26
    -163.28(-0.90%)

  • S&P 500
    3,811.15
    -18.19(-0.48%)

  • DOW
    30,932.37
    -469.64(-1.50%)

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2510-0.0074 (-2.86%)
At close: 3:53PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
Total Revenue
21,078
20,319
1,948
937.654
Cost of Revenue
34,808
34,788
5,048
1,223
Gross Profit
-13,730
-14,469
-3,099
-285.517
Operating Expenses
Research Development
3,784
4,279
801.351
207.5
Selling General and Administrative
27,763
30,409
32,825
8,321
Total Operating Expenses
34,031
36,543
34,245
8,811
Operating Income or Loss
-47,761
-51,012
-37,344
-9,097
Interest Expense
-
-
218.6
0
Total Other Income/Expenses Net
-65,665
-62,947
5,370
93.608
Income Before Tax
-114,235
-113,005
-31,007
-8,842
Income Tax Expense
-293.886
-1,099
-23.611
0
Income from Continuing Operations
-113,137
-111,907
-30,983
-8,842
Net Income
-112,431
-111,141
-30,577
-8,732
Net Income available to common shareholders
-112,431
-111,141
-30,577
-8,732
Basic EPS
-
-0.75
-0.22
-0.10
Diluted EPS
-
-0.75
-0.22
-0.10
Basic Average Shares
-
147,961
141,443
88,448
Diluted Average Shares
-
147,961
141,443
88,448
EBITDA
-
-44,582
-27,341
-8,559